A Hypoxia and Immune Escape-Related Gene Signature for the Diagnosis of Prostate Cancer: An Integrated Bioinformatics Study
International Journal of Medical Sciences · 18.05.2026 · 23 (7) · 2225-2251
DOI: 10.7150/ijms.133397 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, erschienen am 18.05.2026. Verfasst von Hexia Gan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, Tumor Escape, Hypoxia. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
. The model demonstrated high diagnostic accuracy, with area under the curve (AUC) values exceeding 0.9 across all validation cohorts, as confirmed by calibration curves, decision curve analysis, and receiver operating characteristic curves. Functional analysis revealed significant enrichment in translation-related pathways and smooth muscle contraction, and the RiskScore was significantly associated with altered immune cell infiltration in the tumor microenvironment. Regulatory network analysis further uncovered potential upstream regulators and therapeutic agents targeting the key genes. In conclusion, we developed and validated a hypoxia and immune escape-related gene signature with robust diagnostic performance for prostate cancer. Exploratory grouping by the model-derived RiskScore revealed differences in pathway and immune infiltration patterns, suggesting an association between the signature and intratumoral molecular heterogeneity. These exploratory findings primarily serve to characterize the biological features related to the model and provide supplementary clues for understanding molecular alterations in prostate cancer; they should be interpreted with caution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
- Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
- Xiamen Clinical Research Center for Cancer Therapy, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
- Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Gynecology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
- Department of Urology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Zitieren
APA
Gan, H., Jiang, J., Yang, J., Shen, F., Lu, W., Lai, P., Chen, L., Xu, Z., Zhang, J., Guo, J., & Chao, F. (2026). A Hypoxia and Immune Escape-Related Gene Signature for the Diagnosis of Prostate Cancer: An Integrated Bioinformatics Study. International Journal of Medical Sciences, 23(7), 2225-2251. https://doi.org/10.7150/ijms.133397
Vancouver
Gan H, Jiang J, Yang J, Shen F, Lu W, Lai P, et al. A Hypoxia and Immune Escape-Related Gene Signature for the Diagnosis of Prostate Cancer: An Integrated Bioinformatics Study. International Journal of Medical Sciences. 2026;23(7):2225-2251. doi:10.7150/ijms.133397
BibTeX
@article{Gan2026,
author = {Gan, Hexia and Jiang, Jiana and Yang, Jiebin and Shen, Feng and Lu, Weihong and Lai, Peng and Chen, Lingyu and Xu, Zhibing and Zhang, Jianping and Guo, Jianming and Chao, Fan},
title = {A Hypoxia and Immune Escape-Related Gene Signature for the Diagnosis of Prostate Cancer: An Integrated Bioinformatics Study},
journal = {International Journal of Medical Sciences},
year = {2026},
volume = {23},
number = {7},
pages = {2225--2251},
doi = {10.7150/ijms.133397}
}
EUVIMED